Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2017 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Excision Repair Cross-Complementation group 1 (ERCC1) C118T SNP does not affect cellular response to oxaliplatin.
Mutat Res. 2014 Jan;759:37-44. doi: 10.1016/j.mrfmmm.2013.11.001. Epub 2013 Nov 9.
Mutat Res. 2014.
PMID: 24220697
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance.
Reinhardt F, Franken A, Meier-Stiegen F, Driemel C, Stoecklein NH, Fischer JC, Niederacher D, Ruckhaeberle E, Fehm T, Neubauer H.
Reinhardt F, et al.
Cancers (Basel). 2019 Jun 28;11(7):903. doi: 10.3390/cancers11070903.
Cancers (Basel). 2019.
PMID: 31261643
Free PMC article.
Item in Clipboard
A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer.
Lampignano R, Yang L, Neumann MHD, Franken A, Fehm T, Niederacher D, Neubauer H.
Lampignano R, et al.
Int J Mol Sci. 2017 Aug 31;18(9):1885. doi: 10.3390/ijms18091885.
Int J Mol Sci. 2017.
PMID: 28858218
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite